Matsuoka M, Otsuka H, Masuda S, Okano T, Kobayashi T, Takeuchi T, Itokawa Y
New Products Planning and Development Department, Takeda Chemical Industries, Ltd., Tokyo, Japan.
J Nutr Sci Vitaminol (Tokyo). 1989 Aug;35(4):253-66. doi: 10.3177/jnsv.35.253.
Changes in the concentrations of vitamin D and its metabolites in plasma of healthy subjects orally given physiological doses of vitamin D2 by multivitamin or vitamin D liquid preparations were determined and the bioavailability of vitamin D was studied. Separative assay on the D2 and D3 compounds of vitamin D, 25-hydroxyvitamin D (25-OH-D), 24R,25-dihydroxyvitamin D [24,25(OH)2D], and 1 alpha,25-dihydroxyvitamin D [1,25(OH)2D] was performed in plasma of eight healthy male volunteers. When the concentrations of vitamin D and its metabolites in plasma of volunteers were assayed after daily oral administration of 400 IU of vitamin D2 in a form of multivitamin tablet for 1 week, the variations of vitamin D3 and its metabolites in plasma levels were very small. In contrast, the concentrations of 25-OH-D2 and 1,25(OH)2D2 slightly increased after the administration, while neither vitamin D2 nor 24,25(OH)2D2 was detected. A single dose of 4,000 IU of vitamin D2 was orally given to the volunteers in a form of a vitamin D liquid preparation and the hourly variations were observed during 24 h. These concentrations of vitamin D2, 25-OH-D2, and 1,25(OH)2D2 were slightly higher than those of the repeated doses. The result suggests that even the high dose of 4,000 IU has little effect on the plasma levels of vitamin D2 and its metabolites by a single dose, indicating a low risk for hypervitaminosis D.
测定了健康受试者口服多种维生素或维生素 D 液体制剂中生理剂量的维生素 D2 后血浆中维生素 D 及其代谢产物浓度的变化,并研究了维生素 D 的生物利用度。对 8 名健康男性志愿者的血浆进行了维生素 D 的 D2 和 D3 化合物、25-羟基维生素 D(25-OH-D)、24R,25-二羟基维生素 D [24,25(OH)2D] 和 1α,25-二羟基维生素 D [1,25(OH)2D] 的分离测定。当志愿者每日口服 400 IU 多种维生素片形式的维生素 D2 持续 1 周后测定其血浆中维生素 D 及其代谢产物的浓度时,血浆中维生素 D3 及其代谢产物水平的变化非常小。相比之下,给药后 25-OH-D2 和 1,25(OH)2D2 的浓度略有升高,而未检测到维生素 D2 和 24,25(OH)2D2。以维生素 D 液体制剂的形式给志愿者口服单剂量 4000 IU 的维生素 D2,并在 24 小时内观察每小时的变化。这些维生素 D2、25-OH-D2 和 1,25(OH)2D2 的浓度略高于重复给药时的浓度。结果表明,即使单剂量 4000 IU 的高剂量对血浆中维生素 D2 及其代谢产物水平的影响也很小,表明维生素 D 过量的风险较低。